Visiomed enters trials

BIOMEDICAL services developer Visiomed Group has announced that its opthalmic imaging system microEYE, developed in conjunction with Alternative Investment Market-listed CustomVis, has begun a clinical evaluation trial. The microEYE is a hand-held camera system capable of imaging different regions of the eye using a single device. The system is designed for use in the diagnosis and monitoring of eye diseases including cataracts, glaucoma, trachoma, macular degeneration and diabetic retinopathy. In addition to the microEYE system, Visiomed manufactures and sells the Funhaler, an asthma drug delivery device designed specifically for children.

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
49 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer